The approval is the first new treatment advance in more than 30 years for chronic kidney disease for adults with type 1 diabetes.
News|Articles|November 22, 2004
Make room for 'Pharmacy Care OTCs': APhA
Picture this scenario: You walk into a pharmacy and find a new category of nonprescription medications near the pharmacy. These "Pharmacy Care OTCs" are available only in an outlet with a pharmacy, and are intended to treat chronic and asymptomatic conditions as well as other conditions that lend themselves to counseling by a pharmacist.
Advertisement
Advertisement
Related to this article
The approval extends the medication to a younger pediatric population, marking the first FDA-approved treatment for children with this immunodeficiency.
Advertisement
Advertisement
Trending on Drug Topics
1
GLP-1 Therapy Must Prioritize Metabolic Quality Over Weight Loss
2
COVID-19 Vaccine Hesitancy in 2026: How Attitudes Have Shifted
3
Social Media Best Practices for Pharmacists: Why Visibility Matters
4
High-Dose Vaccines Reduce Hospital Stays in Older Adults With Lung Disease
5